The American Association for Cancer Research (AACR) announced in mid-February that it would honor Ludwig Institute Scientific Director Chi Van Dang with the 2024 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research at the Annual Meeting in early April, where Chi will deliver a lecture and officially receive the award. The eponymous award, established in 2007 in honor of the CEO of the AACR, is given every year to a person whose work and leadership have had an enduring impact on the field. A physician-scientist, Chi helped pioneer the modern study of cancer metabolism through his exhaustive study of how the oncogene Myc orchestrates metabolic changes essential to cancer cell growth and survival. More recently, Chi and his colleagues have shown how Myc indirectly disrupts cellular circadian rhythms, linking one fundamental trait of the cancer cell—a disordered metabolism—to another: its broken clock. In issuing the award to Chi, the AACR also noted his many professional contributions as a mentor and scientific leader. These include his role as scientific director of the Ludwig Institute; his former position as Editor-in-Chief of the AACR journal Cancer Research and leadership of numerous committees and advisory groups of the organization; his chairmanship of the National Cancer Institute’s Board of Scientific Advisors, and his membership on the Blue Ribbon Panel of the U.S. Cancer Moonshot initiative.
Back to April 2024 Ludwig Link